Physician

Mohit Narang, M.D.

According to 2025 Medicare claims, Mohit Narang, M.D. (NPI: 1881695351) practices hematology/oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Howard, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY P.A. (NPI: 1396710703; TIN: 113652573) and primary practice location at 21044-3257.

Narang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,480 traditional Medicare patients, billed 284,445 HCPCS/CPT codes, and received $5,279,895 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,164 prescription claims across 207 beneficiaries totaling $4,523,945 in drug costs, led by Pomalyst (Pomalidomide). 2022 DME data shows 109 claims. Open Payments data shows 428 records totaling $530,153. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,657,437 to $5,279,895. Similarly, Part D prescription costs have moved sharply higher in recent years, from $627,890 to $4,523,945. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	458	177,007	$1,657,437
2016	843	240,275	$2,161,401
2017	548	231,029	$2,297,207
2018	718	263,440	$2,715,260
2019	746	225,156	$2,671,531
2020	657	326,211	$4,155,292
2021	618	316,544	$4,250,506
2022	729	276,489	$3,824,272
2023	1,078	271,103	$4,631,966
2024	1,480	284,445	$5,279,895

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	66	429	$627,890
2016	75	385	$605,371
2017	94	420	$450,647
2018	102	510	$1,245,730
2019	90	451	$1,166,374
2020	130	549	$1,765,699
2021	129	627	$2,123,068
2022	126	660	$2,542,981
2023	139	715	$1,632,149
2024	207	1,164	$4,523,945

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$532
2016	N/R	25	$874
2017	N/R	N/R	N/R
2018	N/R	11	$207
2019	N/R	N/R	N/R
2020	N/R	37	$2,348
2021	N/R	16	$307
2022	N/R	109	$4,179
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	562	1,158	$13
80053	Blood test, comprehensive group of blood chemicals	1,037	3,616	$10
83550	Iron binding capacity	555	1,139	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	702	2,529	$8
83540	Iron level	555	1,139	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	30	833	$727,550
Erleada	Apalutamide	42	1,260	$599,519
Revlimid	Lenalidomide	28	784	$517,867
Brukinsa	Zanubrutinib	30	900	$433,691
Abiraterone Acetate	Abiraterone Acetate	107	3,210	$320,274

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	283	$216,402	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	145	$313,751	Exelixis Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohit Narang, M.D.?

Tedicare shows public-source Medicare data for Mohit Narang, M.D. (NPI 1881695351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohit Narang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohit Narang, M.D.?

Mohit Narang, M.D. is linked to MARYLAND ONCOLOGY HEMATOLOGY P.A. (billing NPI 1396710703) in the available physician profile data.

Does Mohit Narang, M.D. have Open Payments data?

Mohit Narang, M.D. has 428 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.